| About
the Industry

Pharmaceuticals Manufacturers
1. Diagnostic
Substances
2. Drug
Delivery Systems
3. Generic
drugs
4. Over-the-Counter
Medications
5. Vitamins,
Nutritionals & Other Health-Related Products
Biotechnology
1. Biopharmaceuticals
& Biotherapeutics
2. Biotechnology
Research Equipment
3. Biotechnology
Research Services
Pharmaceuticals
Distribution & Wholesale
Drug Terms
Pharmaceutical
Glossary
2002 Global Pharma Sales by Region
| World Audited
Market |
2002
sales ($bn) |
%
Global Sales ($) |
%
Growth (constant $) |
| North America |
203.6 |
51% |
+12% |
European Union
|
90.6
|
22
|
+8 |
Rest of Europe
|
11.3
|
3
|
+9 |
Japan
|
46.9
|
12
|
+1 |
Asia, Africa and
Australia
|
31.6
|
8
|
+11 |
| Latin America |
16.5
|
4
|
-10 |
| TOTAL |
$400.6bn |
100.0% |
+8% |
| Source: IMS World Review
2003. Sales cover direct and indirect pharmaceutical channel
purchases in US dollars from pharmaceutical wholesalers and
manufacturers. The figures above represent 52 weeks of sales
data, and include prescription and certain OTC data and represent
manufacturer prices. |
Leading Products in 2002
Global Pharmaceutical Sales*
| Rank |
Audited
World Product Sales |
2002
sales ($bn) |
%
Growth (constant $) |
| 1 |
Lipitor |
8.6
|
+20% |
2
|
Zocor
|
6.2
|
13 |
3
|
Losec/Prilosec |
5.2
|
-19 |
4
|
Zyprexa |
4.0
|
+21 |
5
|
Norvasc |
4.0
|
+6 |
| 6 |
Erypo |
3.8
|
+18 |
| 7 |
Ogastro/Prevacid |
3.6
|
+3 |
| 8 |
Seroxat/Paxil |
3.3
|
+13 |
| 9 |
Celebrex |
3.1
|
- 1 |
| 10 |
Zoloft |
2.9 |
+12 |
| |
Total 10 Leading Products |
$44.7bn |
+11% |
Source: IMS World Review 2003
*Note: 53 weeks US sales data as above. |
|